Replies

don’t forget the following. read the six comments as well.

16 Mar: Trial Site News: Wuhan Institute of Virology (China) Sought to Patent Gilead’s Remdesivir
Gilead’s experimental drug remdesivir shows possibly the most promise of all experimental COVID-19 vaccine prospects as evidenced by China’s reported possible move, via the Wuhan Institute of Virology of the Chinese Academy of Sciences, to patent the drug to treat coronavirus. The experimental drug isn’t licensed or approved anywhere yet, but it surely looks promising. Both remdesivir and chloroquine show promise, according to Chinese authorities...

The Move for a Patent Application
On January 21, it was reported that China’s Wuhan Institute of Virology of the Chinese Academy of Sciences filed a patent for commercial use of remdesivir in China. Also involved is the Military Medicine Institute of that nation. They sought to secure this patent “out of national interest” and noted they were not interested in enforcement should foreign pharma companies seek to collaborate in China to stop the pandemic. An IP attorney based in Shanghai, China observed that the Wuhan Institute of Virology would be wise to secure approval from the drug’s maker and owner—Gilead.

Remdesivir-based Clinical Trials in China
In one clinical trial, Jin Yin-tan Hospital in WuHan and others are conducting a study sponsored by Capital Medical University and the Chinese Academy of Medical Sciences for up to 308 patients with mild to moderate COVID-19 symptoms. In another study concerning patients with severe COVID-19 conditions, Capital Medical University is sponsoring another study led by professor Bin Cao...

It could be deemed a provocative move for the local Wuhan institute to attempt to patent the Gilead drug without working with them...
https://www.trialsitenews.com/wuhan-institute-of-virology-china-sought-to-patent-gileads-remdesivir/

from memory, Epoch Times documentary on covid suggested a descendant of Jiang Zemin was involved in the attempt to patent remdesivir.